United States · 
Who invested in Alexar Therapeutics?
Alexar Therapeutics's investors include Third Point Ventures and New Science Venture.
United States · Series A startup
Who invested in Alexar Therapeutics
One round we have observed, with the 2 investors named in it. Every figure came from a named source, and where the company reported a raise to the SEC itself, that is shown beside it.
Follow Alexar Therapeutics and see its new rounds in your feed.Start following
Funding summaryUpdated 31 Oct 2026
Undisclosedraised across 1 round since 2015, from 1 source
- Latest round
- Series AApr 2015
- Investors
- 2
The rounds
- Apr 2015Series AAmount undisclosed
From a historical funding recordSEC filing: $11M sold, first sale Jan 2014
Everyone who backed them
Missing a round, or an investor who was in one? Tell us.
Quick answers about Alexar Therapeutics
How much has Alexar Therapeutics raised?
Alexar Therapeutics has raised 1 round since 2015, none with a disclosed amount.
When did Alexar Therapeutics last raise?
Alexar Therapeutics's most recent round was a Series A in Apr 2015.
Who backed Alexar Therapeutics first?
Alexar Therapeutics's first round on record, in Apr 2015, was backed by Third Point Ventures and New Science Venture.
What stage is Alexar Therapeutics at?
Alexar Therapeutics's latest named round is a Series A, in Apr 2015.
Where is Alexar Therapeutics based?
Alexar Therapeutics is based in the United States.
Find investors like these
Search every investor by what they have actually funded, then narrow to your stage and market. Free.